RheoTek Medical Inc develops needle-free injector technology that delivers precise injections at predetermined tissue depths for applications in face and hair aesthetics, medical dermatology, and skin cancer treatment. This technology reduces pain during injections while ensuring optimal medication dispersion, enhancing treatment efficacy for medical professionals.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional needle-based injections can cause pain, variable drug dispersion, and inconsistent tissue depth delivery, leading to suboptimal outcomes in aesthetic and dermatological treatments. These limitations can hinder the effectiveness of therapies and reduce patient satisfaction.
Solution
RheoTek Medical is developing a needle-free injection technology platform designed for precise and painless drug delivery in aesthetics, dermatology, and oncology. The platform enables clinicians to administer injections at predetermined tissue depths (epidermis, dermis, fat, or muscle) with optimal drug dispersion. By eliminating the needle, the technology aims to reduce pain, improve treatment efficacy, and enhance the patient experience. The technology is designed to improve and achieve reproducible outcomes while also supporting novel therapeutics.
Target Audience
The primary target audience includes medical professionals in face and hair aesthetics, medical dermatology, and skin cancer treatment.
Features
- Needle-free injection technology for reduced pain and improved patient comfort
- Precise control over injection depth for targeted drug delivery
- Optimized drug dispersion within the tissue
- Platform adaptable for various applications including face and hair aesthetics, medical dermatology, and skin cancer treatment